循环癌症生物标志物
Circulating Cancer Biomarkers.
作者信息
Lokshin Anna, Bast Robert C, Rodland Karin
机构信息
Departments of Pathology, Medicine, and Obstetrics and Gynecology, University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.
Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, 1400 Pressler Street, Unit 1439, Houston, TX 77030, USA.
出版信息
Cancers (Basel). 2021 Feb 15;13(4):802. doi: 10.3390/cancers13040802.
Abstract
Cancer is among the major public health problems worldwide, representing the leading cause of morbidity and mortality in industrialized countries [...].
摘要
癌症是全球主要的公共卫生问题之一，是工业化国家发病和死亡的主要原因[……]。
相似文献
1
Circulating Cancer Biomarkers.循环癌症生物标志物
Cancers (Basel). 2021 Feb 15;13(4):802. doi: 10.3390/cancers13040802.
2
Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives.癌症生物标志物的发现与验证：现状、问题与未来展望
Adv Exp Med Biol. 2015;867:9-26. doi: 10.1007/978-94-017-7215-0_2.
3
The Role of Circulating Biomarkers in Lung Cancer.循环生物标志物在肺癌中的作用。
Front Oncol. 2022 Jan 21;11:801269. doi: 10.3389/fonc.2021.801269. eCollection 2021.
4
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.志贺氏菌感染的全球负担：对疫苗开发和控制策略实施的影响。
Bull World Health Organ. 1999;77(8):651-66.
5
Intermittent Fasting on Human Health and Disease.间歇性禁食对人类健康和疾病的影响
Nutrients. 2023 Oct 24;15(21):4491. doi: 10.3390/nu15214491.
6
Poverty and cancer.贫困与癌症。
IARC Sci Publ. 1997(138):25-39.
7
Epidemiology of sexually transmitted diseases: the global picture.性传播疾病流行病学：全球概况。
Bull World Health Organ. 1990;68(5):639-54.
8
Disease eradication as a public health strategy: is measles next?将疾病根除作为一项公共卫生策略：接下来会是麻疹吗？
World Health Stat Q. 1997;50(3-4):185-7.
9
Road traffic injuries: hidden epidemic in less developed countries.道路交通伤害：欠发达国家的隐性流行病。
J Natl Med Assoc. 2006 Jan;98(1):73-82.
10
Famine-affected, refugee, and displaced populations: recommendations for public health issues.受饥荒影响的人群、难民和流离失所者：公共卫生问题建议
MMWR Recomm Rep. 1992 Jul 24;41(RR-13):1-76.
引用本文的文献
1
Prognostic Value of miR-10a-3p in Non-Small Cell Lung Cancer Patients.miR-10a-3p在非小细胞肺癌患者中的预后价值
Onco Targets Ther. 2024 Nov 14;17:1017-1032. doi: 10.2147/OTT.S475644. eCollection 2024.
2
Primary Care Patient Interest in Multi-Cancer Early Detection for Cancer Screening.初级保健患者对用于癌症筛查的多癌早期检测的兴趣。
J Pers Med. 2023 Nov 16;13(11):1613. doi: 10.3390/jpm13111613.
3
Circulating proteome for pulmonary nodule malignancy.循环蛋白质组学在肺结节良恶性诊断中的应用
J Natl Cancer Inst. 2023 Sep 7;115(9):1060-1070. doi: 10.1093/jnci/djad122.
4
p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins.源自可变剪接的p53和p63蛋白异构体在结直肠癌中具有不同的血清反应性，与经典蛋白相比具有独特的诊断能力。
Cancers (Basel). 2023 Mar 31;15(7):2102. doi: 10.3390/cancers15072102.
5
Factors Likely to Affect the Uptake of Genomic Approaches to Cancer Screening in Primary Care: A Scoping Review.可能影响基层医疗中癌症筛查基因组方法采用率的因素：一项范围综述
J Pers Med. 2022 Dec 10;12(12):2044. doi: 10.3390/jpm12122044.
6
Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer.CXC基序趋化因子1（CXCL1）和趋化因子8（CXCL8）的血浆水平作为腔面A型和B型乳腺癌的诊断生物标志物
J Clin Med. 2022 Nov 12;11(22):6694. doi: 10.3390/jcm11226694.
7
Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer.用于检测早期卵巢癌的多蛋白分类器的开发。
Cancers (Basel). 2022 Jun 23;14(13):3077. doi: 10.3390/cancers14133077.
本文引用的文献
1
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.利用游离 DNA 中的甲基化特征进行敏感且特异的多癌种检测和定位。
Ann Oncol. 2020 Jun;31(6):745-759. doi: 10.1016/j.annonc.2020.02.011. Epub 2020 Mar 30.
2
Modeled Reductions in Late-stage Cancer with a Multi-Cancer Early Detection Test.多癌种早期检测试验可降低晚期癌症的发生率。
Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):460-468. doi: 10.1158/1055-9965.EPI-20-1134. Epub 2020 Dec 16.
3
Detection of Head and Neck Cancer Based on Longitudinal Changes in Serum Protein Abundance.基于血清蛋白质丰度的纵向变化检测头颈部癌症。
Cancer Epidemiol Biomarkers Prev. 2020 Aug;29(8):1665-1672. doi: 10.1158/1055-9965.EPI-20-0192. Epub 2020 Jun 12.
4
Cancer statistics, 2020.癌症统计数据，2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
5
Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy.液体活检中的基于血液的癌症生物标志物：一种有前途的非侵入性组织活检替代方法。
Int J Mol Sci. 2018 Sep 21;19(10):2877. doi: 10.3390/ijms19102877.
6
Detection and localization of surgically resectable cancers with a multi-analyte blood test.通过多分析物血液检测对外科可切除癌症进行检测和定位。
Science. 2018 Feb 23;359(6378):926-930. doi: 10.1126/science.aar3247. Epub 2018 Jan 18.
7
Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples.利用纵向临床前样本评估血清癌胚抗原（CEA）、细胞角蛋白19片段（CYFRA21-1）和癌抗原125（CA125）用于早期检测结直肠癌。
Br J Cancer. 2015 Jul 14;113(2):268-74. doi: 10.1038/bjc.2015.202. Epub 2015 Jun 2.
8
PSA Screening for Prostate Cancer.前列腺癌的前列腺特异性抗原筛查
Am Fam Physician. 2015 May 1;91(9):Online.
9
Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.在一项大型前瞻性队列研究中，将诊断前血清生物标志物作为胰腺癌的早期检测工具。
PLoS One. 2014 Apr 18;9(4):e94928. doi: 10.1371/journal.pone.0094928. eCollection 2014.
10
Evolution and dynamics of pancreatic cancer progression.胰腺癌演进与动力学。
Oncogene. 2013 Nov 7;32(45):5253-60. doi: 10.1038/onc.2013.29. Epub 2013 Feb 18.
Zotero 插件